# Rapport Therapeutics, Inc. (RAPP) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Rapport Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RAPP/mda/fy2025/): filed 2026-03-10; accession 0001193125-26-099360 (https://www.sec.gov/Archives/edgar/data/2012593/000119312526099360/rapp-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RAPP/mda/fy2024/): filed 2025-03-11; accession 0000950170-25-036828 (https://www.sec.gov/Archives/edgar/data/2012593/000095017025036828/rapp-20241231.htm)

Back to /company/RAPP/